{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-21-012126","form_type":"8-K","ticker":"PBSV","cik":"0001304161","company_name":"Pharma-Bio Serv, Inc.","filed_at":"2021-11-15T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.959062+00:00","generated_at":"2026-06-28T08:11:13.125291+00:00","sec_items":["8.01","9.01"],"event_type":"dividend","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Pharma-Bio Serv declares $0.075 special dividend payable January 3, 2022","bullets":["Board declared a special cash dividend of $0.075 per share.","Dividend payable on or about January 3, 2022 to shareholders of record December 15, 2021.","Company is a regulatory and compliance consulting firm serving pharma and biotech industries."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-21-012126","json":"https://secwatch.observer/filing/0001654954-21-012126.json","markdown":"https://secwatch.observer/filing/0001654954-21-012126.md","text":"https://secwatch.observer/filing/0001654954-21-012126.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1304161/000165495421012126/0001654954-21-012126-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1304161/000165495421012126/pbsv_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T08:11:13.125291+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}